TORRANCE, Calif.--(BUSINESS WIRE)--March 17, 1999--Total Renal Care Holdings, Inc. (NYSE:TRL) today announced the appointment of Andrea M. Benko, 43, to Vice President of Corporate Development, Mergers and Acquisitions. Ms. Benko will co-lead Total Renal Care's merger and acquisition teams where she will be focusing on the development of TRL's strategic alliance program with hospitals and non-profit organizations as well as pursuing merger and acquisition opportunities. Ms. Benko will report to Victor Chaltiel, Chairman, President and CEO of Total Renal Care Holdings, Inc.
    Since 1998, Ms. Benko has served as an independent health care consultant to various organizations, including TRL. Ms. Benko served as President and CEO of Florida-based Total Physician Services, Inc., a private HIV physician practice management company, from 1996 to 1998. From 1994 to 1996, she served as President and CEO of California-based Vesicare, Inc., a private physician practice management company with a focus on women's health care.
    From 1990 to 1994, Ms. Benko worked with Mr. Chaltiel in a number of positions, including Executive Vice President at both Abbey Health Care Group, Inc. and Total Pharmaceutical Care, Inc., where she lead the marketing, sales and business development areas.
    Ms. Benko holds a Masters Degree in Business Administration from the Harvard Business School and a Bachelors of Science degree in Nursing from Wayne State University.
    Torrance, California-based Total Renal Care Holdings, Inc. is the second largest domestic and largest independent worldwide provider of integrated dialysis services for patients suffering from chronic kidney failure. The company owns and operates high-quality, freestanding kidney dialysis centers and home peritoneal dialysis programs in 34 states, as well as Washington, D.C., Puerto Rico, Guam, Argentina and Europe, and also provides high-quality acute hemodialysis services to inpatients at approximately 290 hospitals. As of February 1, 1999, TRL operated 522 outpatient dialysis facilities and provided services to more than 40,500 patients, including approximately 2,900 patients in 35 centers under TRL management. TRL additionally operates ESRD laboratory and pharmacy facilities as well as vascular access management, transplant services and ESRD clinical research programs.
    For information on Total Renal Care Holdings, Inc., via facsimile at no cost, call 1-800-PRO-INFO and dial company code TRL.

    CONTACT: Total Renal Care Inc.
             Rich Lester, 212/794-9348 (investor relations)
             John E. King, 310/792-2600
                        or
             The Financial Relations Board
             Haris Tajyar, 310/442-0599 (general information)
             Moira Conlon, 310/442-0599 (investor contact)
             Marjorie Ornston, 310/442-0599 (media contact)
             Kathy Brunson, 312/266-7800 (investor contact)